DocGo (NASDAQ:DCGO) Reaches New 1-Year High – What’s Next?

DocGo Inc. (NASDAQ:DCGO)’s share price reached a new 52-week high during trading on Friday . The company traded as high as $4.91 and last traded at $4.94, with a volume of 432578 shares. The stock had previously closed at $4.48.

Analyst Ratings Changes

Separately, Needham & Company LLC reissued a “buy” rating and issued a $7.00 price target on shares of DocGo in a research report on Thursday, January 16th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, DocGo presently has an average rating of “Buy” and an average target price of $6.10.

DocGo Trading Up 11.7 %

The company has a 50-day moving average price of $4.24 and a 200 day moving average price of $3.72. The stock has a market capitalization of $510.76 million, a P/E ratio of 17.86, a price-to-earnings-growth ratio of 12.36 and a beta of 0.97.

DocGo (NASDAQ:DCGO) last posted its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.01. The firm had revenue of $138.68 million for the quarter, compared to analyst estimates of $139.59 million. DocGo had a return on equity of 8.90% and a net margin of 4.35%. During the same quarter in the prior year, the company earned $0.05 EPS. As a group, research analysts expect that DocGo Inc. will post 0.25 earnings per share for the current year.

Insider Buying and Selling at DocGo

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the stock in a transaction on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now directly owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On DocGo

A number of hedge funds have recently modified their holdings of the stock. Matrix Asset Advisors Inc. NY acquired a new position in DocGo in the fourth quarter worth $424,000. SG Americas Securities LLC raised its stake in shares of DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock worth $183,000 after purchasing an additional 4,905 shares in the last quarter. Harbor Capital Advisors Inc. lifted its holdings in DocGo by 37.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock valued at $5,647,000 after purchasing an additional 363,391 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of DocGo by 151.1% during the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after purchasing an additional 66,097 shares during the period. Finally, Franklin Resources Inc. raised its position in shares of DocGo by 11.6% in the third quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company’s stock valued at $3,933,000 after buying an additional 124,348 shares in the last quarter. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.